{
  "trial_id": "NCT00770120",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, Zubrod performance status, ANC, platelet count, serum bilirubin, AST, ALT, serum creatinine, creatinine clearance, prior systemic therapeutic regimens, prior platinum-based chemotherapy, prior neoadjuvant/adjuvant therapy, presence of CNS metastases, history of pulmonary embolism, INR, presence of bleeding diathesis or coagulopathy, HIV status, gastrointestinal tract disease, history of other malignancies, time since last systemic therapy, time since last major surgery, time since last radiotherapy, prior use of corticosteroids, prior mTOR inhibitor therapy, concurrent immunization status, concurrent antiretroviral therapy, concurrent investigational therapy, concurrent anticancer agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Performance Status",
          "Zubrod performance status"
        ],
        [
          "Prior Systemic Regimens",
          "prior systemic therapeutic regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Histology",
        "Number of Metastatic Sites",
        "Weight Loss Last 6 Months"
      ],
      "remaining_candidate_features": [
        "ANC",
        "platelet count",
        "serum bilirubin",
        "AST",
        "ALT",
        "serum creatinine",
        "creatinine clearance",
        "prior platinum-based chemotherapy",
        "prior neoadjuvant/adjuvant therapy",
        "presence of CNS metastases",
        "history of pulmonary embolism",
        "INR",
        "presence of bleeding diathesis or coagulopathy",
        "HIV status",
        "gastrointestinal tract disease",
        "history of other malignancies",
        "time since last systemic therapy",
        "time since last major surgery",
        "time since last radiotherapy",
        "prior use of corticosteroids",
        "prior mTOR inhibitor therapy",
        "concurrent immunization status",
        "concurrent antiretroviral therapy",
        "concurrent investigational therapy",
        "concurrent anticancer agents"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Performance Status (Zubrod), Prior Systemic Therapy Regimens, Platelet Count, Serum Bilirubin, AST/ALT Levels, Serum Creatinine, Creatinine Clearance, Prior Pulmonary Embolism, INR Levels, Prior Malignancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Performance Status",
          "Performance Status (Zubrod)"
        ],
        [
          "Prior Systemic Regimens",
          "Prior Systemic Therapy Regimens"
        ]
      ],
      "remaining_reference_features": [
        "Histology",
        "Number of Metastatic Sites",
        "Weight Loss Last 6 Months"
      ],
      "remaining_candidate_features": [
        "Platelet Count",
        "Serum Bilirubin",
        "AST/ALT Levels",
        "Serum Creatinine",
        "Creatinine Clearance",
        "Prior Pulmonary Embolism",
        "INR Levels",
        "Prior Malignancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Zubrod Performance Status, Prior Systemic Therapeutic Regimens, Prior Platinum-Based Chemotherapy, Measurable or Nonmeasurable Disease, ANC, Platelet Count, Serum Bilirubin, AST or ALT, Serum Creatinine, Creatinine Clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Histology",
          "Measurable or Nonmeasurable Disease"
        ],
        [
          "Prior Systemic Regimens",
          "Prior Systemic Therapeutic Regimens"
        ],
        [
          "Performance Status",
          "Zubrod Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Number of Metastatic Sites",
        "Weight Loss Last 6 Months"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Prior Platinum-Based Chemotherapy",
        "ANC",
        "Platelet Count",
        "Serum Bilirubin",
        "AST or ALT",
        "Serum Creatinine",
        "Creatinine Clearance"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, Zubrod performance status, histological subtype of malignant mesothelioma, prior systemic therapeutic regimens, time since last platinum-based chemotherapy, ANC, platelet count, serum bilirubin, AST or ALT, serum creatinine, creatinine clearance, presence of CNS metastases, prior surgical procedures, prior radiotherapy, presence of bleeding diathesis or coagulopathy, HIV status, presence of other prior malignancies.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Histology",
          "histological subtype of malignant mesothelioma"
        ],
        [
          "Prior Systemic Regimens",
          "prior systemic therapeutic regimens"
        ],
        [
          "Performance Status",
          "Zubrod performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Number of Metastatic Sites",
        "Weight Loss Last 6 Months"
      ],
      "remaining_candidate_features": [
        "time since last platinum-based chemotherapy",
        "ANC",
        "platelet count",
        "serum bilirubin",
        "AST or ALT",
        "serum creatinine",
        "creatinine clearance",
        "presence of CNS metastases",
        "prior surgical procedures",
        "prior radiotherapy",
        "presence of bleeding diathesis or coagulopathy",
        "HIV status",
        "presence of other prior malignancies."
      ]
    }
  }
}